Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
IntroductionAnticoagulant is the cornerstone of the management of VTE at the cost of a non-negligible risk of bleeding. Reliable and validated clinical tools to predict thromboembolic and hemorrhagic events are crucial for individualized decision-making for the type and duration of anticoagulant tre...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2023-08-01
|
| Sarja: | Frontiers in Cardiovascular Medicine |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1132156/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|